Genesis Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Genesis Biopharma Inc
TickerIOVA
CIK #0001425205
CUSIP462260100
SectorEnergy & Transportation - Arrangement Of Transportation Of Freight & Cargo
Address1601 N Sepulveda Blvd, #632, Manhattan Beach, CA 90266
Source [EDGAR]
CIK Filing 2011 - 2025
[0001425205] 10-K
[0001425205] 10-Q
[0001425205] 3
[0001425205] 4
[0001425205] 5
[0001425205] 8-K
[0001425205] D
[0001425205] SC 13D
[0001425205] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01] 81946.9
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17] 4.6
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03] 7.7
State Street Corp Iovance Biotherapeutics Inc [2023-02-02] 9.32
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30] 5.8
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04] 6.11
ARK Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11] 10.43
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14] 5.1
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11] 8.6
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14] 2.5
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14] 9.9
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14] 5.4
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13] 6.75
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25] 6.7
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13] 6.1
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13] 3.92
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07] 8.4
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13] 0.6
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12] 5.55
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12] 6.7
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11] 7.31
BlackRock Inc Lion Biotechnologies Inc [2016-01-28] 6.6
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17] 0.76
FMR LLC Lion Biotechnologies Inc [2014-07-10] 0.0
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02] 7.197
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03] 40.47
[2013-01-09] None
Form 3/4/5 Filer 2011 - 2025
Iovance Biotherapeutics Inc
Roche Corleen M.
Rosinack Matthew W.
Weiser Michael
Dukes Iain D.
Yarno Wendy L
Countouriotis Athena
Maynard Ryan D
Kirby Daniel Gordon
Bellemin Jean-Marc
Puri Raj K.
Vogt Frederick G
Graf Finckenstein Friedrich
Bilinsky IGOR
Rothbaum Wayne P.
McPeak Merrill A
Dixon Wendy L
Swartzburg Michael
Fardis Maria
Morris Timothy E
Hillsberg Sanford
Venkatesan Jay
Valle Franco
Schiffman Gregory T
Henderson Molly
Fischkoff Steven A.
Lotze Michael
Hawkins ELMA
Bender James G.
ACM Capital Partners, LLC
Ayer Capital Management, LP
Ayer Capital Partners, LLC
Radvanyi Laszlo
Handelman Michael D
Bristol Investment Fund Ltd
Bristol Capital LLC
Singh Manish
Voyticky David J
Kessler Paul L
Form 13F Holdings
Firm Period DFND Voting Shares
MHR Fund Management LLC [2025-06-30] SOLE 28,967,103 28,967,103
Vanguard Group Inc [2025-06-30] SOLE 0 24,600,993
BlackRock, Inc. [2025-06-30] SOLE 22,385,419 23,236,812
Long Focus Capital Management LLC [2025-06-30] SOLE 11,820,000 11,820,000
State Street Corp [2025-06-30] DFND 9,209,378 9,890,525
Millennium Management LLC [2025-06-30] SOLE 9,330,223 9,330,223
Invenomic Capital Management LP [2025-06-30] SOLE 8,294,663 8,294,663
Morgan Stanley [2025-06-30] DFND 6,091,118 6,450,933
Geode Capital Management LLC [2025-06-30] DFND 6,189,058 6,189,058
Citadel Advisors LLC [2025-06-30] DFND 5,120,188 5,120,188
Renaissance Technologies LLC [2025-06-30] SOLE 4,887,200 4,887,200
Goldman Sachs Group Inc [2025-06-30] DFND 4,704,423 4,749,876
Two Sigma Investments LP [2025-06-30] SOLE 4,633,451 4,633,451
Principal Financial Group Inc [2025-06-30] DFND 4,601,441 4,601,441
Bank of America Corp /DE/ [2025-06-30] DFND 1,164,726 4,029,568
Palo Alto Investors LP [2025-06-30] SOLE 3,429,329 3,429,329
Soleus Capital Management LP [2025-06-30] SOLE 3,261,707 3,261,707
Susquehanna International Group LLP [2025-06-30] OTR 2,071,472 2,936,172
Dimensional Fund Advisors LP [2025-06-30] SOLE 2,462,497 2,684,753
Royal Bank of Canada [2025-06-30] DFND 2,341,083 2,359,530
Orion Investment Co [2025-06-30] SOLE 0 2,338,563
Two Sigma Advisers LP [2025-06-30] SOLE 2,293,000 2,334,900
Jane Street Group LLC [2025-06-30] DFND 2,073,871 2,314,471
Northern Trust Corp [2025-06-30] DFND 2,075,680 2,078,903
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,916,486 1,916,486
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 1,866,411 1,866,411
Tang Capital Management LLC [2025-06-30] OTR 0 1,800,000
UBS Group AG [2025-06-30] DFND 1,671,802 1,779,412
Rice Hall James & Associates LLC [2025-06-30] SOLE 1,243,514 1,591,575
Balyasny Asset Management LP [2025-06-30] SOLE 1,507,782 1,507,782
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com